Effectiveness of strengthened stimulation during acupuncture for the treatment of allergic rhinitis: study protocol for a randomized controlled trial.
Effectiveness of strengthened stimulation during acupuncture for the treatment of allergic rhinitis: study protocol for a randomized controlled trial.
复制标题
针灸强化刺激治疗过敏性鼻炎的有效性:随机对照试验研究方案
DOI:
10.1186/1745-6215-15-301
复制
发表时间:
2014-07-24
期刊:
影响因子:
2.5
通讯作者:
Li M
中科院分区:
文献类型:
--
作者:
Chen Q;Zhang Q;Jiang L;Li X;Liu Y;Xie Y;Mu S;Liu Y;Wang X;Yu Y;Li M
BackgroundThe traditional Chinese theory of acupuncture emphasizes that the intensity of acupuncture must reach a threshold to generatede qi(a specific and compound sensation during the acupuncture), which is necessary to achieve the best therapeutic effect. However, the notion thatde qimust be achieved for maximum benefit has not been confirmed by modern scientific evidence. This study aims to compare the efficacy of acupuncture with either strong (intended to elicitde qi) or weak stimulation among patients with allergic rhinitis.Methods/DesignThis study compares real versus sham acupuncture in 140 patients with a history of persistent allergic rhinitis (PER) or intermittent allergic rhinitis (IAR) and with a positive skin prick test (SPT). The trial will be conducted in the Teaching Hospital of Chengdu University of Traditional Chinese Medicine (China). In the study, patients will be randomly assigned into two groups by computer-generated randomization and assessed prior to treatment. They will then receive 12 sessions of treatments for 4 consecutive weeks and have a follow-up phase lasting 12 weeks. The main outcome measures include the primary and secondary indicators. Primary indicators are subjective symptoms scores as evaluated by visual analogue scales (VAS), rhinoconjunctivitis quality of life questionnaires (RQLQ), and the Modified Massachusetts General Hospital acupuncture sensation scale, Chinese version (C-MMASS). The secondary indicators are the results of laboratory examinations, such as serum allergen-specific immunoglobulin E (sIgE) nasal inflammatory cells counts (mast cells, eosinophils, and T cells), and nitric oxide concentration in nasal excretion. The use of anti-allergic medication will also be recorded as one of the secondary indicators. Furthermore, adverse events will be recorded and analyzed. Intention-to-treat analysis (ITT) and per-protocol (PP) analysis will be performed to test and verify the results in this trial.DiscussionThe results of this trial will demonstrate the efficacy of using acupuncture to treat allergic rhinitis and verify whether the effectiveness of acupuncture is related to the needle sensationde qi.Trial registrationChinese Clinical Trial Registry: ChiCTR-TRC-13003594 (registered on 16 August 2013, and the first patient was randomized on 27 September 2013).
登录
查看更多内容
影响因子:
5.7
作者:
Xue, CCL;English, R;Li, CG
通讯作者:
Li, CG
影响因子:
6.1
作者:
JUNIPER, EF;GUYATT, GH
通讯作者:
GUYATT, GH
影响因子:
2.6
作者:
Kong, Jian;Gollub, Randy;Kaptchuk, Ted J.
通讯作者:
Kaptchuk, Ted J.
影响因子:
12.4
作者:
Choi, S. M.;Park, J. -E.;Baoyan, L.
通讯作者:
Baoyan, L.
DOI:
10.1093/ecam/nep006
发表时间:
2010-06
期刊:
Evidence-based complementary and alternative medicine : eCAM
影响因子:
--
作者:
Lim S
通讯作者:
Lim S